A PROSPECTIVE EVALUATION OF N-BUTYL CYANOACRYLATE FOR PERCUTANEOUS SCLEROTHERAPY OF SYMPTOMATIC SIMPLE RENAL CYST
• 2016
معلومات البحث
المؤلفون
AMR EL-DAKHAKHNY, TAREK SOLIMAN, AHMED M. AL-ADL, TAREK EL-KARAMANY
الكلمات المفتاحية
N-butyl cyanoacrylate, sclerotherapy, cystic kidney.
المجلة العلمية
Not Available
الناشر
Not Available
المجلد
Not Available
العدد
Not Available
الصفحات
Not Available
publication.type
International
رابط البحث
Not Available
المواد المرفقة
Not Available
الملخص
Purpose: To assess the safety and efficacy of n-butyl cyanoacrylate (NBCA) and Iodized oil mixture as sclerotherapy for symptomatic simple renal cysts under ultrasound guidance.
Materials and Methods: This prospective study conducted between June 2013 and October 2015, included 33 patients (22 males and 11 females) with 41 symptomatic simple renal cysts (> 5 cm). The mean age + SD was 54.5 + 11.4 (range 41 to 76) years. Before procedure, cyst volume was evaluated by US and non-contrast enhanced CT. Percutaneous real-time aspiration and injection of mixture of NBCA and iodized oil under ultrasound guidance was done. After the procedure, patients were followed up from 3 to 12 months with periodic US examinations. Primary endpoint is complete collapse or decrease in cyst diameter > 50% and elimination of symptoms. Failure was defined as decreased cyst volume < 50% and/or persistence of symptoms.
Results: The mixture of NBCA and iodized oil was technically successful as sclerosing therapy for managing symptomatic simple renal cysts. During median follow up period of 6 months (range 3 to 12), complete disappearance was detected in 27/41 (65.9%), reduced diameter and dis-appearance of symptoms in 11/41 (26.8) and failed procedure (due to recurrence) was detected in 3/41 (7.3%). In all the cases with failure, the pre-procedure cyst diameter was ≥10 cm. After sclerotherapy, fever (
Materials and Methods: This prospective study conducted between June 2013 and October 2015, included 33 patients (22 males and 11 females) with 41 symptomatic simple renal cysts (> 5 cm). The mean age + SD was 54.5 + 11.4 (range 41 to 76) years. Before procedure, cyst volume was evaluated by US and non-contrast enhanced CT. Percutaneous real-time aspiration and injection of mixture of NBCA and iodized oil under ultrasound guidance was done. After the procedure, patients were followed up from 3 to 12 months with periodic US examinations. Primary endpoint is complete collapse or decrease in cyst diameter > 50% and elimination of symptoms. Failure was defined as decreased cyst volume < 50% and/or persistence of symptoms.
Results: The mixture of NBCA and iodized oil was technically successful as sclerosing therapy for managing symptomatic simple renal cysts. During median follow up period of 6 months (range 3 to 12), complete disappearance was detected in 27/41 (65.9%), reduced diameter and dis-appearance of symptoms in 11/41 (26.8) and failed procedure (due to recurrence) was detected in 3/41 (7.3%). In all the cases with failure, the pre-procedure cyst diameter was ≥10 cm. After sclerotherapy, fever (
أعضاء هيئة التدريس - جامعة بنها